Concentra Group Holdings Parent, Inc.
NYSE•CON
CEO: Mr. William Keith Newton
Sector: Healthcare
Industry: Medical - Equipment & Services
Listing Date: 2010-05-25
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.
Contact Information
4714 Gettysburg Road, PO Box 2034, Mechanicsburg, PA, 17055, United States
717-972-1100
Market Cap
$2.76B
P/E (TTM)
17.8
61.2
Dividend Yield
1.2%
52W High
$24.17
52W Low
$18.55
52W Range
Rank41Top 44.9%
4.0
F-Score
Modified Piotroski Analysis
Based on 4-year fundamentals
Average • 4 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2022-2025
Financial Dashboard
Q3 2025 Data
Revenue
$572.80M+16.98%
4-Quarter Trend
EPS
$0.38+7.71%
4-Quarter Trend
FCF
$39.42M-22.35%
4-Quarter Trend
2025 Q3 Earnings Highlights
Key Highlights
Revenue Growth Nine Months Revenue $1.62B YTD, up 13.2% for nine months ended September 30, 2025, driven by volume and acquisitions.
Net Income Attributable Growth Net income attributable to Company $49.8M Q3 2025, showing improvement from $44.3M reported in Q3 2024.
Major Acquisitions Completed Completed Nova ($265.0M) and Pivot Onsite ($54.4M) acquisitions, expanding onsite clinic footprint significantly in 2025.
Risk Factors
Ongoing Litigation Exposure Ongoing litigation including data breach lawsuits and DOJ physical therapy billing investigation pose potential liabilities.
Labor Cost Inflation Pressure Labor intensive industry faces rising wage expenses due to inflation and persistent labor shortages impacting margins.
Variable Interest Rate Risk Variable rate debt exposes interest expense to market rate fluctuations, partially mitigated by derivative contracts.
Outlook
Debt Repayment Activity Made $35.0M voluntary repayment on Revolving Credit Facility in October 2025; availability remains strong at $428.0M.
Shareholder Capital Return Board authorized $100M share repurchase program funded by cash on hand, authorization expires December 31, 2027.
Interest Rate Hedging Strategy Derivative contracts limit variable interest rate exposure on term loan principal through February 29, 2028.
Peer Comparison
Revenue (TTM)
OGN$6.30B
XRAY$3.62B
$3.29B
Gross Margin (Latest Quarter)
ACHC96.4%
CPRX82.9%
ALVO69.3%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| HAE | $3.32B | 19.5 | 19.4% | 50.1% |
| CPRX | $2.90B | 13.3 | 26.4% | 0.3% |
| HCM | $2.77B | 5.8 | 46.9% | 5.3% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
7.2%
Steady Growth
4Q Net Income CAGR
30.9%
Profitability Improved
Cash Flow Stability
100%
Strong Cash Flow
Research & Insights
Next earnings:Mar 2, 2026
EPS:$0.22
|Revenue:-
Reports
All Years
Form 10-Q - Q3 2025
Period End: Sep 30, 2025|Filed: Nov 6, 2025|Revenue: $572.80M+17.0%|EPS: $0.38+7.7%MeetForm 10-Q - Q2 2025
Period End: Jun 30, 2025|Filed: Aug 7, 2025|Revenue: $550.79M+15.2%|EPS: $0.35-14.6%MissForm 10-Q - Q1 2025
Period End: Mar 31, 2025|Filed: May 7, 2025|Revenue: $500.75M+7.1%|EPS: $0.31-20.5%MeetForm 10-K - FY 2024
Period End: Dec 31, 2024|Filed: Mar 3, 2025|Revenue: $1.90B+3.4%|EPS: $1.30-8.5%BeatForm 10-Q - Q3 2024
Period End: Sep 30, 2024|Filed: Nov 6, 2024|Revenue: $489.64M+3.3%|EPS: $0.35-16.7%MeetForm 10-Q - Q2 2024
Period End: Jun 30, 2024|Filed: Aug 27, 2024|Revenue: $477.92M+2.3%|EPS: $0.41-2.4%Miss